BayMed Venture Partners
Venture capitalSan Francisco · Pre-Seed–Series A
Investment thesis
BayMed targets disruptive innovation addressing unmet clinical needs in medical devices and digital health. The firm combines deep clinical and operational expertise with global sourcing capabilities to identify and mentor early-stage companies in North America and Israel. They employ a results-driven, exit-focused methodology and actively partner with portfolio companies to guide growth and value creation across the healthcare ecosystem.
Source: firm website, verified Jul 21, 2026.
Frequently asked questions
- What stage does BayMed Venture Partners invest at?
- BayMed Venture Partners invests at the Pre-Seed, Seed, Series A stages.
- What sectors does BayMed Venture Partners focus on?
- BayMed Venture Partners focuses on Digital Health, Medical Devices.
- Where is BayMed Venture Partners located?
- BayMed Venture Partners is headquartered in San Francisco, US.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.
A European investment firm established in 2016 by former Index Ventures life sciences professionals with over 20 years of experience in drug discovery and therapeutic development for unmet medical needs.